Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, "Babes-Bolyai" University, 5-7 Clinicilor Street, 400006, Cluj-Napoca, Romania.
Department of Genetics, Genomics and Experimental Pathology, The Oncology Institute "Prof. Dr. Ion Chiricuta", 34-36 Republicii Street, 400015, Cluj-Napoca, Romania.
Eur J Nutr. 2023 Sep;62(6):2347-2363. doi: 10.1007/s00394-023-03166-0. Epub 2023 May 4.
The aim of this review is to highlight the potential of garlic phytoconstituents as antitumor agents in colorectal cancer management based on their molecular mechanisms of action, while asking if their consumption, as part of the human diet, might contribute to the prevention of colorectal cancer.
To gather information on appropriate in vitro, in vivo and human observational studies on this topic, the keywords "Allium sativum", "garlic", "colorectal cancer", "antitumor effect", "in vitro", "in vivo", "garlic consumption" and "colorectal cancer risk" were searched in different combinations in the international databases ScienceDirect, PubMed and Google Scholar. After duplicate and reviews removal, 61 research articles and meta-analyses published between 2000 and 2022 in peer-reviewed journals were found and included in this review.
Garlic (Allium sativum) proves to be a rich source of compounds with antitumor potential. Garlic-derived extracts and several of its individual constituents, especially organosulfur compounds such as allicin, diallyl sulfide, diallyl disulfide, diallyl trisulfide, diallyl tetrasulfide, allylmethylsulfide, S-allylmercaptocysteine, Z-ajoene, thiacremonone and Se-methyl-L-selenocysteine were found to possess cytotoxic, cytostatic, antiangiogenic and antimetastatic activities in different in vitro and in vivo models of colorectal cancer. The molecular mechanisms for their antitumor effects are associated with the modulation of several well-known signaling pathways involved in cell cycle progression, especially G1-S and G2-M transitions, as well as both the intrinsic and extrinsic apoptotic pathways. However, even though in various animal models some of these compounds have chemopreventive effects, based on different human observational studies, a diet rich in garlic is not consistently associated with a lower risk of developing colorectal cancer.
Independent of the impact of garlic consumption on colorectal cancer initiation and promotion in humans, its constituents might be good candidates for future conventional and/or complementary therapies, based on their diverse mechanisms of action.
本综述旨在强调大蒜植物成分作为结直肠癌治疗中的抗肿瘤剂的潜力,基于其作用机制,同时探讨其作为人类饮食的一部分,是否有助于预防结直肠癌。
为了收集关于该主题的适当的体外、体内和人类观察性研究信息,使用“Allium sativum”、“garlic”、“colorectal cancer”、“antitumor effect”、“in vitro”、“in vivo”、“garlic consumption”和“colorectal cancer risk”等关键词,在 ScienceDirect、PubMed 和 Google Scholar 等国际数据库中进行了不同组合的搜索。经过重复和综述筛选,发现并纳入了 2000 年至 2022 年期间在同行评审期刊上发表的 61 篇研究文章和荟萃分析。
大蒜(Allium sativum)被证明是一种具有抗肿瘤潜力的化合物的丰富来源。大蒜衍生提取物及其几种单体成分,特别是有机硫化合物,如蒜素、二烯丙基硫化物、二烯丙基二硫化物、二烯丙基三硫化物、二烯丙基四硫化物、烯丙基甲基硫化物、S-烯丙基巯基半胱氨酸、Z-ajoene、硫代丙烯酮和硒代甲基-L-硒代半胱氨酸,在不同的结直肠癌细胞体外和体内模型中具有细胞毒性、细胞生长抑制、抗血管生成和抗转移活性。其抗肿瘤作用的分子机制与调节几个已知的参与细胞周期进程的信号通路有关,特别是 G1-S 和 G2-M 转变,以及内在和外在的凋亡途径。然而,尽管在各种动物模型中,其中一些化合物具有化学预防作用,但基于不同的人类观察性研究,富含大蒜的饮食并不总是与结直肠癌发病风险降低相关。
无论大蒜消费对人类结直肠癌发生和促进的影响如何,其成分都可能是基于其多样化的作用机制,成为未来常规和/或补充治疗的良好候选药物。